Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2062094> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Q2062094 subject Q7214357.
- Q2062094 subject Q7348603.
- Q2062094 subject Q7403984.
- Q2062094 subject Q8255706.
- Q2062094 subject Q8639167.
- Q2062094 abstract "Pramlintide (Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt.".
- Q2062094 atcPrefix "A10".
- Q2062094 atcSuffix "BX05".
- Q2062094 bioavailability "30.0".
- Q2062094 casNumber "151126-32-8".
- Q2062094 drugbank "DB01278".
- Q2062094 fdaUniiCode "D3FM8FA78T".
- Q2062094 pubchem "16132446".
- Q2062094 thumbnail Pramlintide_sequence.svg?width=300.
- Q2062094 wikiPageExternalLink symlin.cfm.
- Q2062094 wikiPageExternalLink www.symlin.com.
- Q2062094 wikiPageWikiLink Q1029907.
- Q2062094 wikiPageWikiLink Q11364.
- Q2062094 wikiPageWikiLink Q12206.
- Q2062094 wikiPageWikiLink Q14821391.
- Q2062094 wikiPageWikiLink Q14865246.
- Q2062094 wikiPageWikiLink Q164386.
- Q2062094 wikiPageWikiLink Q1767180.
- Q2062094 wikiPageWikiLink Q2035485.
- Q2062094 wikiPageWikiLink Q21163221.
- Q2062094 wikiPageWikiLink Q311213.
- Q2062094 wikiPageWikiLink Q3535686.
- Q2062094 wikiPageWikiLink Q37525.
- Q2062094 wikiPageWikiLink Q424611.
- Q2062094 wikiPageWikiLink Q482044.
- Q2062094 wikiPageWikiLink Q6740853.
- Q2062094 wikiPageWikiLink Q7214357.
- Q2062094 wikiPageWikiLink Q731938.
- Q2062094 wikiPageWikiLink Q7348603.
- Q2062094 wikiPageWikiLink Q7403984.
- Q2062094 wikiPageWikiLink Q7873.
- Q2062094 wikiPageWikiLink Q8255706.
- Q2062094 wikiPageWikiLink Q8639167.
- Q2062094 wikiPageWikiLink Q9377.
- Q2062094 wikiPageWikiLink Q9618.
- Q2062094 atcPrefix "A10".
- Q2062094 atcSuffix "BX05".
- Q2062094 bioavailability "30".
- Q2062094 casNumber "151126".
- Q2062094 drugbank "DB01278".
- Q2062094 pubchem "16132446".
- Q2062094 unii "D3FM8FA78T".
- Q2062094 type ChemicalSubstance.
- Q2062094 type Drug.
- Q2062094 type ChemicalObject.
- Q2062094 type Thing.
- Q2062094 type Q8386.
- Q2062094 comment "Pramlintide (Symlin) is an injectable amylin analogue drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca). Pramlintide is sold as an acetate salt.".
- Q2062094 label "Pramlintide".
- Q2062094 depiction Pramlintide_sequence.svg.